Mark J. Casey
CIK: 0001415297
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NOVAVAX INC
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Mar 3, 2026NVAX
NOVAVAX INC
Exercise(M)Direct37.5K shares- - Mar 3, 2026NVAX
NOVAVAX INC
Tax Payment(F)Direct11.4K shares at avg. $9.49$108K - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectNon-Statutory Stock Option NQ
152K shares- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectRestricted Stock Units
101K shares- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectNon-Statutory Stock Opotion NQ
152K shares at avg. $9.09- - Mar 1, 2026NVAX
NOVAVAX INC
Exercise(M)Direct4K shares- - Mar 1, 2026NVAX
NOVAVAX INC
Tax Payment(F)Direct1.2K shares at avg. $10.14$12K - Dec 11, 2025NVAX
NOVAVAX INC
Exercise(M)Direct41.9K shares- - Dec 11, 2025NVAX
NOVAVAX INC
Tax Payment(F)Direct12.7K shares at avg. $6.69$85K - Mar 3, 2025NVAX
NOVAVAX INC
Award(A)Direct2025 Restricted Stock Units RSU
112.5K shares- - Mar 3, 2025NVAX
NOVAVAX INC
Award(A)Direct2025 Non-statutory Stock Option NQ
169K shares at avg. $7.87- - Mar 1, 2025NVAX
NOVAVAX INC
Exercise(M)Direct4K shares- - Mar 1, 2025NVAX
NOVAVAX INC
Tax Payment(F)Direct1.2K shares at avg. $8.33$10K - Dec 11, 2024NVAX
NOVAVAX INC
Tax Payment(F)Direct12.7K shares at avg. $8.82$112K - Dec 11, 2024NVAX
NOVAVAX INC
Exercise(M)Direct41.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVAX NOVAVAX INC | Exercise(M) | 37,500 | - | $0 | Direct |
| Mar 3, 2026 | NVAX NOVAVAX INC | Tax Payment(F) | 11,378 | $9.49 | $107,977 | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Non-Statutory Stock Option NQ | 152,000 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Restricted Stock Units | 101,000 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Non-Statutory Stock Opotion NQ | 152,000 | $9.09 | - | Direct |
| Mar 1, 2026 | NVAX NOVAVAX INC | Exercise(M) | 4,000 | - | $0 | Direct |
| Mar 1, 2026 | NVAX NOVAVAX INC | Tax Payment(F) | 1,214 | $10.14 | $12,310 | Direct |
| Dec 11, 2025 | NVAX NOVAVAX INC | Exercise(M) | 41,899 | - | - | Direct |
| Dec 11, 2025 | NVAX NOVAVAX INC | Tax Payment(F) | 12,713 | $6.69 | $85,050 | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award(A) 2025 Restricted Stock Units RSU | 112,500 | - | - | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award(A) 2025 Non-statutory Stock Option NQ | 169,000 | $7.87 | - | Direct |
| Mar 1, 2025 | NVAX NOVAVAX INC | Exercise(M) | 4,000 | - | - | Direct |
| Mar 1, 2025 | NVAX NOVAVAX INC | Tax Payment(F) | 1,214 | $8.33 | $10,113 | Direct |
| Dec 11, 2024 | NVAX NOVAVAX INC | Tax Payment(F) | 12,713 | $8.82 | $112,129 | Direct |
| Dec 11, 2024 | NVAX NOVAVAX INC | Exercise(M) | 41,900 | - | $0 | Direct |
1-15 of 15 transactions
About Casey Mark J
Casey Mark J (SEC CIK 0001415297) files insider reports with the SEC as EVP, Chief Legal Officer of NOVAVAX INC (NVAX).
Signal8 holds 7 ownership filings by Casey Mark J, all Form 4s, filed between Dec 13, 2024 and Mar 9, 2026. Those filings report 15 transactions, from Dec 11, 2024 to Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Casey Mark J's filings is in GAITHERSBURG, MD.
Recent filings by Casey Mark J
- Mar 3, 2026: Option exercise of NVAX shares (Form 4, code M).
- Mar 3, 2026: Tax withholding of NVAX shares (Form 4, code F).
- Mar 2, 2026: Grants or awards of NVAX derivative securities (3 lines, Form 4, code A).
- Mar 1, 2026: Option exercise of NVAX shares (Form 4, code M).
- Mar 1, 2026: Tax withholding of NVAX shares (Form 4, code F).
Other insiders filing for NOVAVAX INC (NVAX)
- Rodgers Richard J, Director
- King Rachel K., Director
- DOUGLAS RICHARD, Director
- MCGLYNN MARGARET G, Director
- MOTT DAVID M, Director
- Alton Gregg H, Director